Billiontoone, Inc. $BLLN Shares Newly Acquired by Landscape Capital Management L.L.C.

Landscape Capital Management L.L.C. purchased a new position in shares of Billiontoone, Inc. (NASDAQ:BLLN – Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 5,570 shares of the company’s stock, valued at approximately $593,000.

Several other institutional investors and hedge funds also recently made changes to their positions in BLLN. Wasatch Advisors LP boosted its position in Billiontoone by 40.2% in the second quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock valued at $62,160,000 after buying an additional 148,446 shares in the last quarter. Aberdeen Group plc bought a new position in Billiontoone in the 3rd quarter valued at $19,565,000. Penn Capital Management Company LLC boosted its holdings in Billiontoone by 2.3% in the third quarter. Penn Capital Management Company LLC now owns 132,636 shares of the company’s stock valued at $14,143,000 after acquiring an additional 3,034 shares during the last quarter. Perceptive Advisors LLC boosted its stake in shares of Billiontoone by 26.1% in the 1st quarter. Perceptive Advisors LLC now owns 91,812 shares of the company’s stock valued at $7,248,000 after purchasing an additional 19,000 shares during the last quarter. Finally, Renaissance Technologies LLC bought a new position in Billiontoone in the first quarter valued at approximately $4,046,000.

Billiontoone Price Performance

BLLN opened at $89.92 on Friday. The stock has a market cap of $4.30 billion and a P/E ratio of 104.68. Billiontoone, Inc. has a 12 month low of $61.96 and a 12 month high of $150.44. The company has a quick ratio of 10.89, a current ratio of 11.25 and a debt-to-equity ratio of 0.16. The company has a fifty day simple moving average of $106.40 and a 200 day simple moving average of $97.99.

Insiders Place Their Bets

In other Billiontoone news, CTO David Tsao sold 20,000 shares of the business’s stock in a transaction dated Wednesday, September 9th. The stock was sold at an average price of $98.77, for a total value of $1,975,400.00. Following the completion of the transaction, the chief technology officer directly owned 1,000 shares of the company’s stock, valued at approximately $98,770. The trade was a 95.24% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 25,001 shares of the stock in a transaction dated Monday, November 2nd. The stock was sold at an average price of $109.24, for a total value of $2,731,109.24. Following the completion of the sale, the chief executive officer owned 16,667 shares of the company’s stock, valued at $1,820,703.08. This trade represents a 60.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 252,777 shares of company stock worth $26,737,151. Corporate insiders own 50.22% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on BLLN shares. Wall Street Zen lowered Billiontoone from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Guggenheim raised their target price on Billiontoone from $125.00 to $128.00 and gave the stock a “buy” rating in a report on Thursday, October 1st. Piper Sandler decreased their target price on Billiontoone from $140.00 to $130.00 and set an “overweight” rating for the company in a research report on Tuesday, November 10th. Zacks Research raised Billiontoone from a “strong sell” rating to a “hold” rating in a research note on Friday, October 2nd. Finally, Weiss Ratings upgraded shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Monday, November 9th. Seven investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Billiontoone presently has an average rating of “Moderate Buy” and a consensus price target of $124.38.

Read Our Latest Analysis on BLLN

Billiontoone Company Profile

(Free Report)

BillionToOne is a molecular diagnostics company that develops and provides genetic testing for prenatal care and cancer care. Its tests use the company’s molecular counting technology to detect and measure genetic material in patient samples. In prenatal care, BillionToOne offers screening for chromosomal conditions and certain inherited single-gene disorders. Its UNITY platform includes tests designed to assess fetal risk using a pregnant patient’s blood sample. The company also provides oncology testing, including services designed to help characterize tumors and detect cancer-related genetic material.

Recommended Stories

Want to see what other hedge funds are holding BLLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Billiontoone, Inc. (NASDAQ:BLLN – Free Report).

Institutional Ownership by Quarter for Billiontoone (NASDAQ:BLLN)

Receive News & Ratings for Billiontoone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Billiontoone and related companies with MarketBeat.com's FREE daily email newsletter.